Effects of CSFS and their combinations with chemotherapeutic agents (CH) on leukemic blasts (LB) in children (MTT-ASSAY)

Advances in Experimental Medicine and Biology

Volumn 457, Issue , 1999, Pages 585-592

  Litvinova, E ^a   Gurova, K ^a   Chimishkian, K ^a   Mentkevich, G ^a  

^a Cancer Research Center   (Russian Federation)

Author keywords

Ara C; DOX; Growth factors; Leukemia; MTT assay; VP 16

Indexed keywords

ANTINEOPLASTIC AGENT; COLONY STIMULATING FACTOR; CYTARABINE; DOXORUBICIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; BLAST CELL CRISIS; BONE MARROW CELL; CHILD; COMPARATIVE STUDY; DRUG EFFECT; DRUG POTENTIATION; DRUG SCREENING; HUMAN; INFANT; METHODOLOGY; PATHOLOGY; PRESCHOOL CHILD;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS; BLAST CRISIS; BONE MARROW CELLS; CHILD; CHILD, PRESCHOOL; COLONY-STIMULATING FACTORS; CYTARABINE; DOXORUBICIN; DRUG SCREENING ASSAYS, ANTITUMOR; DRUG SYNERGISM; ETOPOSIDE; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; LEUKEMIA, MYELOCYTIC, ACUTE;

EID: 0032613260     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-4811-9_65     Document Type: Article

References (22)

1. Koistinen P., Wang C., Yang GS, et al. OCI/AML-4 an acute myeloblastic leukemia cell line: Regulation and response to cytosine arabinoside. Leukemia 1991, 5, 704-711.
2. Tafuri A., Andreeff M. Kinetic rationale for cytokine-induced recruitment of myeloblastic leukemia followed by cycle-specific chemotherapy in vitro. Leukemia 1990, 4, 826-834.
3. Metelitsa L., Shmelev V., Shvedova E., Popov A., Mentkevich G. 25 Effects of cytokines and their combinations with Ara-C on short term culture of tumor cells from children with acute leukemia by the MTT-assay. In Pieters R., Kaspers G.J.L., Veerman A.J.P. (eds): "Drug resistance in Leukemia and Lymphoma II". Harwood academic publishers, 1997, 209-216.
4. Clarkson B., Strife A., Fried J., et al. Studies of cellular proliferation in human leukemia. IV. Behavior of leukemic cells in 3 adults with acute leukemia given continuous infusion of 3H-thymidine for 8 to 10 days. Cancer, 1970, 26, 1-19.
5. Raza A., Maheshwari Y., Preisler HD. Differences in cell cycle characteristics among patients with acute nonlymphocytic leukemia. Blood, 1987, 69(6), 1647-1653.
6. Hirt A., Antic V., Wang E., Luthy AR., Leibundgut R., et al. Acute lymphoblastic leukaemia in children: cell proliferation without rest. Br J Haematology 1997,96, 366-368.
7. Campana D., Janossy G.: Proliferatoin of normal and malignant human immature lymphoid cells. Blood, 1988, 71, 1201.
8. Cannistra SA, Groshek P., Griffin JD. Granulocyte-macrophage colony-stimulating factor enhances the cytotoxic effects of cytosine arabinoside in acute myeloblastic leukemia and on the myeloid blast crisis phase of chronic myelogenous leukemia. Leukemia, 1989, 3, 328-334.
9. Sundman- Engberg B., Tidelfelt U., Paul C, 24 In vitro studies of growth factors in combination with cytostatic drugs on human leukemia cells. In Pieters R., Kaspers G.J.L., Veerman A.J.P. (eds): "Drug resistance in Leukemia and Lymphoma II". Harwood academic publishers, 1997, 203-208.
10. Hederson E.S., Lister T.A., Greaves M.F. (eds): "Leukemia. Sixth edition", 1996.
11. Bhalla K., Ibrado AM, Holladay C., Bullock G. Hemopoietic growth factors (HGFs) G-CSF and Il-3 improve the antileukemic selectivity of high-dose Ara-C (HIDAC). Blood 1991, 78 (Suppl 1), 425 (abstr).
12. Smith MA, Singer CRG, Pallister CJ, Smith JG. The effect of haemopoietic growth factors on the cell cycle of AML progenitors and their sensitivity to cytosine arabinoside in vitro. Br J Haematology, 1995, 90, 767-773.
13. Koistinen P., Wang C., Curtis JE, McCulloch EA. Granulocyte-macrophage colony-stimulating factor and interleukin-3 protect leukemia blast cells from Ara-C toxity. Leukemia 1991, 5, 789-795.
14. Kaplinsky C., Lotem J., Sachs L. Protection of human myeloid leukemia cells against doxorubicin-induced apoptosis by granulocyte-macrophage colony-stimulating factor and interleukin-3. Leukemia, 1996, 10, 460-465.
15. Estey E., Thall PF, Kantarjian H., et al: Treatment of newly diagnosed acute myelogenous leukemia with granulocyte-macrophage colony-stimulating factor (GM-CSF) before and during continuous infusion high-dose Ara-C+daunorubicin: Comparison to patients treated without GM-CSF. Blood 1992, 79, 2246-2255.
16. Bettelheim P., Valent P., Andreeff M., Tafuri A., Haimi J., et al. Recombinant human granulocyte-macrophage colony-stimulating factor in combination with standard induction chemotherapy in de novo acute myeloid leukemia. Blood 1991, 77, 700-711.
17. Archimbaud E., Fenaux P., Reiffers J., Cordonnier C., Leblond V., Travade P., Troussard X., et al. Granulocyte-macrophage colony-stimulating factor in association to timed-sequential chemotherapy with mitoxantrone, etoposide and cytarabine for refractory acute myelogenous leukemia. Leukemia 1993, 7, 372-377.
18. DiGiusto D., Chen S., Combs J., et al. Human fetal bone marrow early progenitors for T, B, and myeloid cells are exclusively in the population expressing high levels of CD34. Blood 1994, 84, 421
19. Kurtzberg J., Waldmann TA, Davey MP, et al. CD7+, CD4-, CD8- acute leukemia: A syndrome of malignant pluripotent lymphohematopoietic cells. Blood 1989, 73, 381.
20. Serrano J., Roman J., Sanchez J., Torres A. Myeloperoxidase gene expression in acute lymphoblastic leukaemia. Br J Haematology 1997, 97, 841-843.
21. Matsushita K., Arama N., Ohtsubo H., Fujiwara H., et al. Granulocyte colony-stimulating factor-induced proliferation of primary adult T-cell leukemia cells. Br J Haematology 1996, 96, 715-723.
22. Preisler HD, Raza A., Larson R., Goldberg J., Tricot G., et al. Some reasons for the lack of progress in the treatment of acute myelogenous leukemia. Leuk Res 1991, 15(9), 773-780.